Invisalign maker Align Technology (ALGN) crushed fourth-quarter expectations late Wednesday, leading ALGN stock to retake its 200-day moving average.
X
During the December quarter, sales for the clear teeth-straightening device maker climbed roughly 6% to $956.7 million, beating forecasts for $933.7 million, according to FactSet. Adjusted profit came in at $2.42 per share, up 13% and above projections for $2.18.
Align expects total 2024 sales to advance by a mid-single-digit percentage. Analysts following ALGN stock estimated $4.02 billion in sales, up 4%.
In after-hours trading on the stock market today, ALGN stock jumped more than 10% to 294.40. Shares climbed above their 200-day line for the first time since December, according to MarketSmith.com.
Follow Allison Gatlin on X, the platform formerly known as Twitter, at @IBD_AGatlin.
YOU MAY ALSO LIKE:
Pfizer Reports Surprise Profit Despite Continued Covid Sales Downfall
Vertex’s Alternative To Opioids Is ‘Not A Game-Changer,’ Says Analyst
Watch IBD’s Investing Strategies Show For Actionable Market Insights
See Stocks On The List Of Leaders Near A Buy Point
IBD Stock Of The Day: See How To Find, Track And Buy The Best Stocks
Signup bonus from